BamSEC and AlphaSense Join Forces
Learn More

Amedisys Inc

NASDAQ: AMED    
Share price (3/12/25): $92.12    
Market cap (3/12/25): $3.534 billion

Material Contracts Filter

EX-10.39
from 10-K 8 pages Limited Good Reason Waiver
12/34/56
EX-10.38
from 10-K 2 pages Bonus Repayment Agreement
12/34/56
EX-10.37
from 10-K 2 pages Bonus Repayment Agreement
12/34/56
EX-10.36
from 10-K 2 pages Bonus Repayment Agreement
12/34/56
EX-10.35
from 10-K 2 pages Jennifer Griffin Re: Accelerated Payments and Potential Repayment Obligations
12/34/56
EX-10.34
from 10-K 2 pages Richard Ashworth Re: Accelerated Payments and Potential Repayment Obligations
12/34/56
EX-10.33
from 10-K 2 pages Jennifer Griffin Re: Accelerated Payments and Potential Repayment Obligations
12/34/56
EX-10.32
from 10-K 9 pages Limited Good Reason Waiver
12/34/56
EX-10.31
from 10-K 11 pages Separation Agreement and General Release
12/34/56
EX-10.1
from 8-K 4 pages Re: Merger Agreement Waivers
12/34/56
EX-10.1
from 10-Q 2 pages Third Amendment to the Amedisys, Inc. 2018 Omnibus Incentive Compensation Plan
12/34/56
EX-10.34
from 10-K 2 pages Adam Holton Re: Accelerated Payments and Potential Repayment Obligations
12/34/56
EX-10.33
from 10-K 2 pages Richard Ashworth Re: Accelerated Payments and Potential Repayment Obligations
12/34/56
EX-10.32
from 10-K 8 pages Limited Good Reason Waiver
12/34/56
EX-10.31
from 10-K 8 pages Limited Good Reason Waiver
12/34/56
EX-10.1
from 8-K 8 pages Termination Agreement
12/34/56
EX-10.1
from 10-Q 12 pages Unless and Until This Agreement Is “Effective,” It, and the Discussions About Entering Into Such an Agreement, Are Confidential Under F.R.E. 408 and Its State Counterparts and Not Admissible. Separation Agreement and General Release
12/34/56
EX-10.27
from 10-K 15 pages Amendment No. 1 to Amedisys Holding, L.L.C. Amended and Restated Severance Plan for Executive Officers
12/34/56
EX-10.1
from 10-Q 30 pages Mutual Separation Agreement and General Release
12/34/56
EX-10.1
from 8-K 9 pages Amedisys Holding, L.L.C. Severance Plan for Chief Executive Officer January 2022
12/34/56